SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 17th, 2024 • Harvard Apparatus Regenerative Technology, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledApril 17th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 15, 2024, between Harvard Apparatus Regenerative Technology, Inc., a Delaware corporation (the “Company”), and [_____________] (the “Purchaser”).
AMENDED AND RESTATED SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 12th, 2024 • Rubini Jonathan Brian • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 12th, 2024 Company Industry JurisdictionThis Amended and Restated Securities Purchase Agreement (this “Agreement”), dated as of April 11, 2024, comes to correct and replace the Securities Purchase Agreement dated as of September 29, 2023 (the “Original Agreement”), between G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
CARMELL CORPORATION SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 4th, 2024 • Carmell Corp • Surgical & medical instruments & apparatus • New York
Contract Type FiledApril 4th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April [__], 2024, by and among Carmell Corporation, a Delaware corporation (the “Company”), and each purchaser identified on the Schedule of Purchasers attached as Schedule I hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 11th, 2024 • Mind Medicine (MindMed) Inc. • Medicinal chemicals & botanical products • New York
Contract Type FiledMarch 11th, 2024 Company Industry JurisdictionEach of the undersigned, Robert Barrow, Chief Executive Officer of Mind Medicine (MindMed) Inc., a corporation incorporated under the laws of the Province of British Columbia (the “Company”), and Schond Greenway, Chief Financial Officer of the Company, on behalf of the Company, does hereby certify, pursuant to Section 2.2(a)(iv) of that certain Securities Purchase Agreement dated March 7, 2024 (the “Securities Purchase Agreement”) by and between the Company and the purchasers identified therein, that:
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 21st, 2024 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledFebruary 21st, 2024 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February , 2024, by and among DarioHealth Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • January 24th, 2024 • Connexa Sports Technologies Inc. • Sporting & athletic goods, nec • Delaware
Contract Type FiledJanuary 24th, 2024 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 19, 2024, between Connexa Sports Technologies Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature page hereto (including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 30th, 2023 • VYNE Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledOctober 30th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 27, 2023, between VYNE Therapeutics Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 10th, 2023 • G Medical Innovations Holdings Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 10th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 29, 2023, between G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 21st, 2023 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledJune 21st, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 21, 2023, by and among DiaMedica Therapeutics Inc., a corporation existing under the laws of British Columbia, Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser,” and collectively, the “Purchasers”). The Company and the Purchasers are sometimes hereinafter referred to each as a “party” and collectively as the “parties.”
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2023 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 5th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May 5, 2023, by and among DarioHealth Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 5th, 2023 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMay 5th, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of May 1, 2023, by and among DarioHealth Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 6th, 2023 • NextPlat Corp • Telephone communications (no radiotelephone) • New York
Contract Type FiledApril 6th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April 5, 2023, between NextPlat Corp, a Nevada corporation (the “Company”), and the purchaser identified on the signature pages hereto (including its successors and assigns, “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • April 6th, 2023 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledApril 6th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 31, 2023, between Biostage, Inc., a Delaware corporation (the “Company”), and [_____________] (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2023 • PolyPid Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 31st, 2023 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of March 29, 2023, by and among PolyPid Ltd., an Israeli company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 7th, 2023 • Marizyme Inc • Pharmaceutical preparations • Florida
Contract Type FiledFebruary 7th, 2023 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 6, 2023, between Marizyme, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • December 22nd, 2022 • Intelligent Bio Solutions Inc. • Surgical & medical instruments & apparatus • Delaware
Contract Type FiledDecember 22nd, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of December 21, 2022, between Intelligent Bio Solutions Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 18th, 2022 • Progressive Care Inc. • Retail-drug stores and proprietary stores • Florida
Contract Type FiledNovember 18th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 16, 2022 (the “Signing Date”), between Progressive Care Inc., a Delaware corporation (the “Company”), and NextPlat Corp, a Nevada corporation (including its successors and assigns, “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 27th, 2022 • G Medical Innovations Holdings Ltd. • Surgical & medical instruments & apparatus • New York
Contract Type FiledOctober 27th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of October 20, 2022, between G Medical Innovations Holdings Ltd., a Cayman Islands exempted company (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 16th, 2022 • H-Cyte, Inc. • Surgical & medical instruments & apparatus • New York
Contract Type FiledJune 16th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 8, 2022, by and between H-Cyte, Inc., a Nevada corporation (the “Company”), and each lender party that executes the signature page hereto as a purchaser (each, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 23rd, 2022 • Theralink Technologies, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledMay 23rd, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of April [ ], 2022, between Theralink Technologies, Inc., a Nevada corporation (the “Company”), and each investor identified on the signature pages to this Agreement (each a “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 13th, 2022 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledMay 13th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 12, 2022, between Biostage, Inc., a Delaware corporation (the “Company”), and [_____________] (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 24th, 2022 • Inmune Bio, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledMarch 24th, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of March 21, 2022, between INmune Bio, Inc., a Nevada corporation (the “Company”), and each purchaser identified on the signature pages hereto (the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 2nd, 2022 • DarioHealth Corp. • Surgical & medical instruments & apparatus • New York
Contract Type FiledMarch 2nd, 2022 Company Industry JurisdictionThis SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of February 28, 2022, by and among DarioHealth Corp., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 3rd, 2022 • Theralink Technologies, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledFebruary 3rd, 2022 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January __, 2022, between Theralink Technologies, Inc., a Nevada corporation (the “Company”), and each investor identified on the signature pages to this Agreement (each a “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 30th, 2021 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledNovember 30th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 26th, 2021, between Biostage, Inc., a Delaware corporation (the “Company”), and David Green (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • November 5th, 2021 • Theralink Technologies, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledNovember 5th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of November 1, 2021, between Theralink Technologies, Inc., a Nevada corporation (the “Company”), and each investor identified on the signature pages to this Agreement (each a “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • October 7th, 2021 • Unique Logistics International Inc • Arrangement of transportation of freight & cargo • New York
Contract Type FiledOctober 7th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of _, 2021, between Unique Logistics International, Inc., a Nevada corporation, (the “Company”), and each Purchaser identified on Schedule A (each, including its successors and permitted assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 27th, 2021 • DiaMedica Therapeutics Inc. • Pharmaceutical preparations • New York
Contract Type FiledSeptember 27th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 26, 2021, among DiaMedica Therapeutics Inc., a corporation existing under the laws of British Columbia, Canada (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 8th, 2021 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledSeptember 8th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of September 1, 2021, between Biostage, Inc., a Delaware corporation (the “Company”), and ______ (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • August 5th, 2021 • Ascent Solar Technologies, Inc. • Semiconductors & related devices • Colorado
Contract Type FiledAugust 5th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of August 2, 2021, between Ascent Solar Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • July 20th, 2021 • Akari Therapeutics PLC • Pharmaceutical preparations • New York
Contract Type FiledJuly 20th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of July 6, 2021, between Akari Therapeutics, PLC, a public company with limited liability incorporated under the laws of England and Wales (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • June 22nd, 2021 • Biostage, Inc. • Surgical & medical instruments & apparatus • Massachusetts
Contract Type FiledJune 22nd, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of June 17, 2021, between Biostage, Inc., a Delaware corporation (the “Company”), and ___________ (the “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • May 19th, 2021 • Theralink Technologies, Inc. • Pharmaceutical preparations • Nevada
Contract Type FiledMay 19th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of May 12, 2021, between Theralink Technologies, Inc., a Nevada corporation (the “Company”), and each investor identified on the signature pages to this Agreement (each a “Purchaser”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • March 31st, 2021 • CFN Enterprises Inc. • Services-business services, nec • New York
Contract Type FiledMarch 31st, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of January 6, 2021, between CFN Enterprises Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • February 18th, 2021 • Creative Medical Technology Holdings, Inc. • Biological products, (no disgnostic substances) • Nevada
Contract Type FiledFebruary 18th, 2021 Company Industry JurisdictionThis Securities Purchase Agreement (this “Agreement”) is dated as of February 11, 2021, between Creative Medical Technology Holdings, Inc., a Nevada corporation (the “Company”), and BHP Capital NY, Inc. (the “Purchaser”).